Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
Inhibition of N-myristoyltransferase has been validated pre-clinically as a target for the treatment of fungal and trypanosome infections, using species-specific inhibitors. In order to identify inhibitors of protozoan NMTs, we chose to screen a diverse subset of the Pfizer corporate collection agai...
Saved in:
Main Authors: | Andrew S Bell (Author), James E Mills (Author), Gareth P Williams (Author), James A Brannigan (Author), Anthony J Wilkinson (Author), Tanya Parkinson (Author), Robin J Leatherbarrow (Author), Edward W Tate (Author), Anthony A Holder (Author), Deborah F Smith (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
N-Myristoyltransferases as antileishmanial targets: a piggyback approach with benzoheterocyclic analogues
by: Luis Otávio Junqueira, et al.
Published: (2019) -
Half Hours with the Lower Animals Protozoans, Sponges, Corals, Shells, Insects, and Crustaceans
by: Holder, Charles Frederick, 1851-1915 -
Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi.
by: Linda J Herrera, et al.
Published: (2016) -
Using 5-Nitroimidazole Derivatives against Neglected Tropical Protozoan Diseases: Systematic Review
by: Micheel M. Vichi-Ramírez, et al.
Published: (2024) -
Novel 2,5-Diketopiperazines with In Vitro Activities against Protozoan Parasites of Tropical Diseases
by: Isabela P. Ceravolo, et al.
Published: (2024)